UT MD Anderson Research Uncovers Link Between Inflammaging and Age-Related Diseases, Identifies Potential Therapeutic Target
Research conducted at UT MD Anderson, led by Rugang Zhang, Ph.D., Chair of Experimental Therapeutics, is deepening the understanding of 'inflammaging'—the chronic inflammation that develops throughout the body as individuals age. This chronic inflammation gradually damages cells and tissues, accelerating the aging process and contributing to various age-related diseases, including cancer. Dr. Zhang's team has identified a key mechanism where R-loops, nucleic acid structures made of RNA and DNA, are exported from the cell nucleus into the cytoplasm in senescent cells, triggering a persistent inflammatory response. They discovered that two proteins facilitate this R-loop exit. Notably, the lab found that KPT-330, an FDA-approved drug for certain lymphomas and leukemias that blocks the protein XPO-1 (one of the proteins involved in R-loop export), suppressed inflammaging in preclinical models. This suppression led to lowered systemic inflammatory markers, reversed age-related body composition changes, and ext...